Voruciclib 2-(2-氯-4-(三氟甲基)苯基)-5,7-二羟基-8-((2R,3S)-2-(羟基甲基)-1-甲基吡咯烷-3-基)-4H-色烯-4-酮
CAS 1000023-04-0 MFCD100023040
化学结构图
SMILES: CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccc(C(F)(F)F)cc4Cl)oc23)[C@@H]1CO
化学属性
| Mol. Weight | 469.8412 |
|---|---|
| Appearance | Solid powder |
| Solubility | Soluble in DMSO, not in water |
别名和识别编码
| Chemical Name | Voruciclib |
|---|---|
| Formula | C22H19ClF3NO5 |
| Synonym | P1446A05, P1446A-05, P1446A 05, Voruciclib |
| IUPAC Name | 2-(2-Chloro-4-(trifluoromethyl)phenyl)-5,7-dihydroxy-8-((2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl)-4H-1-benzopyran-4-one |
| InChIKey | MRPGRAKIAJJGMM-OCCSQVGLSA-N |
| InChI | InChI=1S/C22H19ClF3NO5/c1-27-5-4-12(14(27)9-28)19-15(29)7-16(30)20-17(31)8-18(32-21(19)20)11-3-2-10(6-13(11)23)22(24,25)26/h2-3,6-8,12,14,28-30H,4-5,9H2,1H3/t12-,14+/m1/s1 |
| Canonical SMILES | O=C1C=C(C2=CC=C(C(F)(F)F)C=C2Cl)OC3=C([C@H]4[C@H](CO)N(C)CC4)C(O)=CC(O)=C13 |
| Chemical Name Translation | 2-(2-氯-4-(三氟甲基)苯基)-5,7-二羟基-8-((2R,3S)-2-(羟基甲基)-1-甲基吡咯烷-3-基)-4H-色烯-4-酮 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
产品应用
- Voruciclib, also known as P1446A-05, is a protein kinase inhibitor specific for the cyclin-dependent kinase 4 (CDK4) with potential antineoplastic activity. CDK4 inhibitor P1446A-05 specifically inhibits CDK4-mediated G1-S phase transition, arresting cell cycling and inhibiting cancer cell growth. The serine/threonine kinase CDK4 is found in a complex with D-type G1 cyclins and is the first kinase to become activated upon mitogenic stimulation, releasing cells from a quiescent stage into the G1/S growth cycling stage; CDK-cyclin complexes have been shown to phosphorylate the retinoblastoma (Rb) transcription factor in early G1, displacing histone deacetylase (HDAC) and blocking transcriptional repression.
